首页> 外文期刊>Research Disclosure >Crisaborole (code AN-2728) a non-steroidal boron containing drug is a phosphodiesterase-4 inhibitor, used for topical treatment of psoriasis and atopic dermatitis
【24h】

Crisaborole (code AN-2728) a non-steroidal boron containing drug is a phosphodiesterase-4 inhibitor, used for topical treatment of psoriasis and atopic dermatitis

机译:非甾体含硼药物Crisaborole(代码AN-2728)是磷酸二酯酶4抑制剂,用于局部治疗牛皮癣和特应性皮炎

获取原文
获取原文并翻译 | 示例
           

摘要

Crisaborole (code AN-2728) a non-steroidal boron containing drug is a phosphodiesterase-4 inhibitor, used for topical treatment of psoriasis and atopic dermatitis. The chemical name of crisaborole is 5-(4-cyanophenoxy)-l-hydroxy-l,3-dihydro-2.1-bena)xaborole and has following structure: US8039451B2 discloses Crisaborole and pharmaceutical formulation containing it. US '451 also discloses process for preparation of Crisaborole in example-4. The process disclosed in the patent suffers from several disadvantages, as it utilizes of flash column chromatography to purify the product it is a cumbersome, expensive and time consuming technique. Further the product is obtained in very low yield and has only 80% purityeven after column purification. Hence, one or more purification steps are required to purify the obtained compound in order to comply with various regulatory requirements.
机译:非甾体含硼药物Crisaborole(代码AN-2728)是磷酸二酯酶4抑制剂,用于局部治疗牛皮癣和特应性皮炎。十字苯硼灵的化学名称是5-(4-氰基苯氧基)-1-羟基-1,3-二氢-2.1-苯那)xaborole,并具有以下结构:US8039451B2公开了十字苯硼灵和包含它的药物制剂。 US'451还公开了实施例4中的Crisaborole的制备方法。该专利中公开的方法具有几个缺点,因为它利用快速柱色谱法来纯化产物,这是一种麻烦,昂贵和费时的技术。此外,即使在柱纯化之后,也以非常低的收率获得产物并且仅具有80%的纯度。因此,为了符合各种法规要求,需要一个或多个纯化步骤来纯化获得的化合物。

著录项

  • 来源
    《Research Disclosure》 |2019年第658期|140-140|共1页
  • 作者

  • 作者单位
  • 收录信息
  • 原文格式 PDF
  • 正文语种 eng
  • 中图分类
  • 关键词

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号